Home/SEC 13D/G/COAGSEC 13D/GCOAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified$COAG$51.75▲ 52.03% YTDHealthcareAug 7, 2026 · ThinkSabio BlogSEC Filing Update: #COAG Hemab Therapeutics Holdings, Inc. : $51.75 Sector: Healthcare | YTD: 🔼+ 52.03% The SEC disclosed Today (07-AUG-2026) that Invus Global Management, LLC has Newly bought 2,295,029 #COAG shares Ownership: 4.9% * Estimated Investment Value: $110.62M https://www.thinksabio.com/reports/isr/COAG 📌 Institutional activity in the last 30 days for #COAG: • Sofinnova Crossover II SLP – Newly bought 2,511,212 shares (05-AUG-2026) • FMR LLC – Newly bought 3,697,837 shares (06-AUG-2026) Share this post🔗Copy LinkMore filings for $COAGCOAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026COAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 5, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G